Events

Upcoming Events ¦ Past Events ¦ Scientific Presentations

Upcoming Presentations

Cowen & Company 32nd Annual Health Care Conference
March 6, 2012, 11:30 a.m. (ET)
Boston, MA

Needham Healthcare Conference
April 3-4, 2012
New York, NY

2012 Healthcare Conference and Industry Presentations

J.P. Morgan Healthcare Conference
January 10, 2012, 1:30 p.m. (PT)
San Francisco, CA

2011 Healthcare Conference and Industry Presentations

Piper Jaffray 23rd Annual Health Care Conference
November 30, 2011, 3:50 p.m. (ET)
New York, NY

Wedbush 2011 Life Sciences Management Access Conference
August 16, 2011, 3:35 p.m. (ET)
New York, NY

Needham & Company 10th Annual Healthcare Conference
April 5, 2011, 9:00 a.m. (ET)
New York, NY

Cowen and Company 31st Annual Health Care Conference
March 8, 2011 11:30 -11:55 a.m. (ET)
Boston, MA

[ back to top ]

2011 Scientific Presentations

Request a copy of Concert's Poster Presentations

C-21191: Deuterated Subtype-Selective GABA(A) Modulator for Spasticity and Neuropathic Pain
Neuroscience 2011
November 12-16, 2011

Deuterated Subtype-Selective GABA(A) Modulators for Cognition Enhancement
Neuroscience 2011
November 12-16, 2011

Single Ascending Dose Pharmacokinetics, Safety and Tolerability of CTP-499, A Novel Agent Being Investigated for Treatment of Chronic Kidney Disease
American Society of Nephrology's Kidney Week 2011
November 8-13, 2011

First Human Exposure Suggests A Unique Metabolic Profile with Multiple Active Species for CTP-499, a Novel Agent for Treatment of Chronic Kidney Disease
American Society of Nephrology's Kidney Week 2011
November 8-13, 2011

CTP-499, a Novel Drug for the Potential Treatment of Chronic Kidney Disease, Has Anti-Fibrotic, Anti-Inflammatory, and Anti-Oxidative Activities with In Vivo Efficacy
American Society of Nephrology's Kidney Week 2011
November 8-13, 2011

Deuterium-Substituted Lapatinib Isotopologs Exhibit Reduction in O-debenzylation and Metabolic Shunting ISSX 2011 North American Regional Meeting
October 16-20, 2011

Structural Elucidation of In Vitro and In Vivo Metabolites of Lapatinib by DCE Platform and HPLC-UV-MSn
2011 ASMS Asilomar Metabolomics Meeting
October 5-9, 2011

Deuterium in Drugs for Cardiovascular Disease: Design and Synthesis of Deuterated Cilostazol and Ranolazine Analogs with Enhanced Metabolic Stability
ACS Fall 2011 National Meeting and Exposition
August 28 – September 1, 2011

Design and Synthesis of Deuterated Darunavir Analogs with Enhanced Pharmacokinetic Properties
ACS Fall 2011 National Meeting and Exposition
August 28 – September 1, 2011

Design and Synthesis of Deuterated Iloprost Analogs with Potential for Enhanced Pharmacokinetic Properties
ACS Fall 2011 National Meeting and Exposition
August 28 – September 1, 2011

C-10068: Novel Sigma-1 Agonist for Epilepsy and Neuroprotection
Antiepileptic Drug Trials XI Conference
April 29, 2011

[ back to top ]